TCT-745 Guideline Based Referral for Septal Reduction Therapy In Patients With Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes: Longitudinal Follow-Up Of A Large, Single-Center Experience

TCT-745 Guideline Based Referral for Septal Reduction Therapy In Patients With Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes: Longitudinal Follow-Up Of A Large, Single-Center Experience

Conclusions Guideline-based referral for septal reduction therapy in drug-refractory HCM patients is associated with low mortality rates for both ASA and myectomy, although there was greater improvement in limiting heart failure symptoms in the younger, lower-risk myectomy patients.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2015-10, Vol.66 (15), p.B304-B304
Hauptverfasser: Kuttab, Johny S, Parmar, Yuvrajsinh, Rowin, Ethan, Sanghai, Saket, Rastegar, Hassan, Maron, Martin, Kimmelstiel, Carey D
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Cardiomyopathy
Cardiovascular
Clinical outcomes
Heart failure
Internal Medicine
Mortality
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Conclusions Guideline-based referral for septal reduction therapy in drug-refractory HCM patients is associated with low mortality rates for both ASA and myectomy, although there was greater improvement in limiting heart failure symptoms in the younger, lower-risk myectomy patients.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2015.08.769